News | April 14, 2025
Fredun secures tender from TNMSC for supply of generic pharma products
The supply of these goods is set to commence within the first quarter of FY26
The supply of these goods is set to commence within the first quarter of FY26
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Strengthening capabilities in Peptide Therapeutics and CDMO services
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Subscribe To Our Newsletter & Stay Updated
